Repertoire Immune Medicines

Developer of T-cell based drugs for the treatment of immune disorders

placeCambridge, Massachusetts, United States calendar_todayFounded 1995 groups46 employees language repertoire.com

Registered entities

Innovation

17 patent families — focus: Chemistry & metallurgy, Human necessities; filing pace steady. Cited 896 times.

YearFilings
20202
20215
20229
20237
20249
20258
20264

Social engagement

Social engagement: 13K social following, 9 posts in the last 12 months — below the industry typical range.

Investor mix

7 investors on record; lead investors include T1D Fund.

Investor typeCountShare
Venture capital343%
Private equity114%
Other / undisclosed343%

Hiring activity

Hires occasionally

2 roles tracked across 2 of the last 12 months

14 May 2026 · Applied Machine Learning/AI Scientist · Cambridge

24 Apr 2026 · Vice President, Head of CMC · Cambridge

24 Sep 2025 · Clinical Trial Manager · Cambridge

5 Aug 2025 · Associate Director in Translational Sciences

Based on job postings tracked across public sources.

Recent activity

7 May 2026
Milestone
regulatory
29 Jan 2026
Partnership
Elix Lilly and Company
22 Dec 2025
Partnership
Pioning Medicines and Pfizer
Coming soon